Addressing Performance, Scalability, and Regulatory Challenges to Accelerate Cell Therapy Manufacturing.
| Publicado en: | BioPharm International Vol. 37; no. 7; pp. 14 - 18 |
|---|---|
| Autores principales: | , , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Jul/Aug2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179074687&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 179074687 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Jul/Aug2024 vid: 37 iid: 7 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 179074687 179074687 179074687 179074687 ppf: 14 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Addressing Performance, Scalability, and Regulatory Challenges to Accelerate Cell Therapy Manufacturing. aug: au: CASHEN, PAUL DECKERS, SUSANNE LADI, RUKMINI sug: subj: Cell Therapy Gene Therapy Immunotherapy Receptors, Cell Surface Consumer Product Safety United States Food and Drug Administration Marketing Product Development Costs and Cost Analysis Government Regulations pubtype: Trade Publication doctype: pictorial tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|